
00380930552240 (باللغة العربية) |
00380930552240 (باللغة العربية) |
Below you can find video testimonials and letters from our patients, their relatives and doctors regarding the effects of stem cell treatment at Cell Therapy Center EmCell. We intentionally do not provide patients' names, as in Ukraine such information is considered medical secrecy.
Patient F.T.G., 47. Amyotrophic lateral sclerosis, cervical form, marked flaccid tetraparesis
Patient B.I., 44. ALS, with cervicothoracic involvement, marked tetraparesis, and bulbar palsy. S.p. disc surgery in 2002
Patient S.M., 68. Amyotrophic lateral sclerosis. Bulbar palsy. Spastic tetraparesis
Patient M.A., 76. Motor neuron disease
Patient M.N., 42. Anti-aging treatment
Patient G.R.C., 67. Anti-aging treatment
Patient K., 52. Menopause
Patient H., 35. Anti-aging treatment
Patient E.M., 49. Dyshormonal neurocirculatory asthenia
Patient M.H., 50. Chronic fatigue syndrome. Remission of lumbar osteochondrosis with moderate muscle tone abnormalities
Patient A.Z., 3. Autism
Patient H.M., 4. Dyspraxia. Autism
Patient V.S., 6. Autism
Patient K.S., 6. Autism
Patient D.P., 7. Autism
Patient B.T., 7. Autism
Patient S.S., 8. Autism spectrum disorder
Patient L.C., 8. Autism
Patient O.M.C., 8. Autism
Patient A.L., 10. Autism. Joint hyperlaxity
Patients K.T. and J.P.T., 9 and 10. Autism
Patient O.N., 9. Autism
Patient M.K. 10. Autism
Patient R.L. 12. Autism
Patient Ch.M.G. 13. Post-hypoxic encephalopathy with speech disturbances. Autism.
Patient J.G., 14. Autism
Patient G.O., 14. Autism
Patient D.L.S., 17. Autism.
Patient R.M., 21. Autism. Toxic hepatitis
Patient D.S., 29. Autism
Patient U.M., 57 C-r glandullae bilateralis; condition after combined therapy; prolongatio morbi
Patient K.J., 3. Post-hypoxic encephalopathy. Cerebral palsy with moderate spastic tetraparesis and cognitive problems
Patient M.W., 6. Cerebral palsy with lower paraparesis. Mental and physical delay
Patient C.W., 6. Cerebral palsy
Patient I.C., 2. Сerebral palsy with moderate left-sided hemiparesis
Patient L.P., 13. Psychomotor delay and secondary immune deficiency
Patient O.H., 13. Developmental delay. Well-managed secondary hypothyroid
Patient M.A., 49. Advanced subcompensated diabetes mellitus, type 2
Patient Z., 57. Type 2 moderate subcompensated diabetes mellitus
Patient A., 54. Advanced decompensated type 2 diabetes mellitus. Ischemic heart disease
Patient J. Sch.-J., 49. Type I diabetes and diabetic neuropathy
Patient I.B., 25. Best's disease (macular dystrophy)
Patient T.P., 67. Chronic heart failure
Patient F.A., 54. Chronic heart failure
Patient A.M., 49. Dilated cardiomyopathy
Patient R.N., 43. Non-nodular polyosteoarthrosis of the large joints (knee, hips) without functional insufficiency of the joints
Patient V.K.S., 54. Non-nodular osteoarthritis of the large joints without functional insufficiency of the joints. Unstable remission of extensive osteochondrosis, vertebrogenic brachialgia, lumboischialgia on the right, and pain. Insomnia. Obstructive sleep apnea
Patient D.P., 56. Osteoarthrosis affecting mainly large joints. Varicose veins of lower extremities
Patient R., 8. Duchenne Muscular Dystrophy
Patient C.M., 10. Muscle dystrophy, stage II
Patient R.T., 12. Duchenne’s Muscular Dystrophy
Patient S.A., 15. Duchenne’s Muscular Dystrophy
Patient P.P., 25. Duchenne’s Muscular Dystrophy
Patient M., 30. Muscular Dystrophy
Patient R. M., 31. Duchenne’s Muscular Dystrophy
Patient H., 42. Multiple sclerosis
Patient V.A., 28. Multiple sclerosis
Patient H.R., 43. Multiple sclerosis; emphysema; pulmonary insufficiency
Patient L.N., 52. Multiple sclerosis
Patient D.M., 29. Remitting-relapsing multiple sclerosis
Patient R.W., 44. Primary progressive cerebrospinal multiple sclerosis with spastic paraparesis of the lower extremities
Patient M.C., 63. Secondary progressive multiple sclerosis with cerebrospinal involvement, spastic paraparesis of lower extremities and urine retention
Patient A.Z.D., 35. Secondary progressive multiple sclerosis with cerebrospinal involvement and spastic paraparesis of the lower extremities and urine retention
Patient N.N., 62. Parkinson's disease
Patient A.A.N., 72. Akinetic-rigid and tremor-dominant Parkinson’s disease, stage II. Stage II grade 2 essential hypertension. Grade I heart failure. Extensive osteochondrosis
Patient W. H., 67. Akinetic-rigid tremor-dominant Parkinsons’ disease, stage II (Hoehn&Yahr)
Patient H.R., 69. Akinetic-rigid and tremor-dominant Parkinson’s disease
Patient J. S. H., 63. Well-managed akinetic-rigid, tremor-dominant Parkinson’s disease
Patient A.S., 9. Type 2 SMA, grade IV S-kyphoscoliosis
Patient M.S., 1. Spinal Muscular Atrophy, type I. Tetraparesis
Patient N.A., 48. Fibromyalgia. Seronegative spondylarthritis. Secondary hyperalgesia. Nodular osteoarthritis. Dyshormonal neurocirculatory asthenia
Patient B.J., 61. Polymyalgia. Polyosteoarthrosis mostly affecting large joints: hip, knee, elbow and shoulder joints
Patient V.C. 51. Dyslipidemia. Diffuse-nodular goiter
Patient K., 39. Spastic paraparesis of the lower extremities
Patient F.S., 34. Organic brain damage. Affective disorder. Insomnia
Patient I.M., 17. Epilepsy. Grade I-II thoracic kyphoscoliosis
Patient N.U., 13. Sensorineural hearing loss
Patient C., 23. Traumatic brain injury
Patient M.B., 60. Chronic obstructive pulmonary disease. Lung emphysema. Diffuse pneumosclerosis
Patient S.N., 5. Williams-Beuren Syndrome